L-carnitine reduces all-cause mortality after a heart attack by 27% according to a meta-analysis of 13 studies.

L-carnitine reduces ventricular arrhythmias after a heart attack by 65% according to a meta-analysis of 13 studies.

L-carnitine reduces development of angina after a heart attack by 40% according to a meta-analysis of 13 studies.

L-carnitine reduces heart failure after a heart attack by 15% according to a meta-analysis of 13 studies.

However, there was a 21% chance that this difference seen between groups was due to random chance (P=0.21), in other words, it was not statistically significant, but this also means that there was a 79% chance the difference was due to the L-carnitine.

This means that it is likely that the L-carnitine following a heart attack also reduces the risk of developing heart failure.

L-carnitine given after a heart attack

• reduces all-cause mortality by 27%
• reduces ventricular arrhythmias by 65%
• reduces development of angina (chest pain) by 40%
• reduces heart failure by 15%
• reduces infarct size

according to a meta-analysis of 13 studies.

The minimum effective dose seems to be 2 grams per day (2,000 mg).

L-carnitine given after a heart attack

• reduces all-cause mortality by 27%
• reduces ventricular arrhythmias by 65%
• reduces development of angina (chest pain) by 40%
• reduces heart failure by 15%
• reduces infarct size

according to a meta-analysis of 13 studies.

The optimum dose seems to be 6-9 grams per day (6,000 to 9,000 mg per day).

A daily dose of 3,000 mg of L-carnitine per day given to people who had suffered a heart attack resulted in a 52% lower risk of all-cause mortality over some number of months according to a meta-analysis of five (5) studies that included 3108 people.